Stem Point Capital LP Gh Research PLC Transaction History
Stem Point Capital LP
- $312 Billion
- Q2 2025
A detailed history of Stem Point Capital LP transactions in Gh Research PLC stock. As of the latest transaction made, Stem Point Capital LP holds 100,826 shares of GHRS stock, worth $1.32 Million. This represents 0.39% of its overall portfolio holdings.
Number of Shares
100,826Holding current value
$1.32 Million% of portfolio
0.39%Shares
1 transactions
Others Institutions Holding GHRS
# of Institutions
39Shares Held
38.5MCall Options Held
0Put Options Held
2.6K-
Bvf Inc San Francisco, CA8.83MShares$116 Million4.23% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.68MShares$101 Million2.05% of portfolio
-
Lynx1 Capital Management LP San Juan, PR6.75MShares$88.5 Million24.35% of portfolio
-
Rtw Investments, LP New York, NY5.54MShares$72.6 Million1.04% of portfolio
-
Cormorant Asset Management, LP Boston, MA2.01MShares$26.3 Million2.47% of portfolio
About GH Research PLC
- Ticker GHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,020,800
- Market Cap $682M
- Description
- GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...